NAICS 446

Health & Personal Care Stores

NAICS 446: Health and personal care stores. US retail pharmacies, drugstores, PBM dynamics, and pharmacy industry trends.

Industry at a Glance

Sector-wide aggregates across all businesses classified under NAICS 446 (2017 classification frame). For specific sub-industries within this sector, see the individual reports below.

In NAICS 2022 this is part of 456, “Health and Personal Care Retailers”, which is broader.

Employment
1.1M
US Census CBP · 2023 · NAICS 2017
Establishments
89K
US Census CBP · 2023 · NAICS 2017
Annual Payroll
$43.0B
US Census CBP · 2023 · NAICS 2017
Avg Annual Wage
$40,288
Derived from US Census CBP · 2023 · NAICS 2017
Market Size
$319.5B
US Census Economic Census · 2017 · NAICS 2017

Industry Overview

Health and personal care stores (NAICS 446) covers retail pharmacies, drugstores, optical goods retailers, and specialty health and wellness stores selling prescription medications, over-the-counter drugs, vitamins, beauty products, and medical supplies directly to consumers. The subsector has undergone dramatic consolidation and structural transformation, with CVS Health, Walgreens Boots Alliance, and Rite Aid historically dominating the pharmacy chain landscape, though Rite Aid's 2023 bankruptcy filing reduced the competitive field.

Prescription dispensing drives the economic engine: pharmacy operations typically generate 70-80% of revenue for major chains, with front-store merchandise (beauty, personal care, OTC medications) providing supplementary margin. Pharmacy benefit manager (PBM) reimbursement rates are the critical profitability variable. CVS Health's ownership of Caremark (the largest PBM) creates vertical integration advantages, while independent pharmacies operating under cooperative banners like Good Neighbor Pharmacy and Health Mart face persistent reimbursement pressure from the three dominant PBMs (Caremark, Express Scripts/Cigna, and OptumRx/UnitedHealth).

The subsector is regulated at both federal and state levels. DEA registration and controlled substance scheduling govern opioid and other scheduled drug dispensing. State boards of pharmacy license individual pharmacists and pharmacy locations. HIPAA privacy requirements apply to all prescription data handling. The expansion of pharmacy scope-of-practice laws in states like California and Oregon now permits pharmacists to prescribe hormonal contraceptives and initiate certain treatments, expanding the clinical role beyond traditional dispensing.

Who Uses These Reports

Trusted by professionals who need verified federal data to make decisions

Investors & PE Firms

Size markets, validate deal theses, and benchmark targets with verified federal data before committing capital

Consultants & Advisors

Deliver data-backed recommendations to clients with sourced and cited industry metrics — Census, BLS, and FRED

Founders & Operators

Validate market entry, benchmark against industry averages, and present credible data to investors and boards

Corporate Strategy Teams

Support expansion planning, M&A due diligence, and executive reporting with NAICS-classified industry data

See what's inside a report

Market sizing, workforce analysis, competitive landscape, regulatory environment — all sourced from Census, BLS, FRED, and SEC EDGAR.

Industry Trends

CVS

CVS Health and Walgreens are each closing 900+ locations through 2026 as e-commerce, reduced front-store traffic, and PBM reimbursement pressure undermine the economic model of traditional drugstore density

02

Amazon Pharmacy and Mark Cuban's Cost Plus Drugs are disrupting prescription pricing transparency and mail-order fulfillment, pressuring brick-and-mortar pharmacy margins on generic medications

03

State pharmacy scope-of-practice expansion in California (SB 493), Oregon, and Colorado now allows pharmacists to prescribe hormonal contraceptives, naloxone, and certain travel medications, creating new clinical revenue streams

PBM

PBM reform legislation advancing in Congress and at FTC targets rebate pass-through requirements and spread pricing practices that independent pharmacists argue suppress reimbursement below dispensing costs

CVS

Specialty pharmacy for high-cost biologics and gene therapies is growing rapidly as a revenue segment, with CVS Specialty, Walgreens-owned AllianceRx, and independents competing for contracts with manufacturers and health plans

Available Reports

1 industry report available for purchase under Health & Personal Care Stores.

Industry Groups

Browse deeper into the NAICS hierarchy.

Frequently Asked Questions

What is NAICS 446? ▾
NAICS 446 classifies retail pharmacies, drugstores, optical goods stores, and specialty health retailers. CVS Health and Walgreens dominate the segment with approximately 17,000 combined US pharmacy locations, though both are executing multi-year store closure programs. The subsector excludes hospital pharmacies and pharmacy benefit managers, which are classified separately.
How do pharmacy benefit managers affect drugstore profitability? ▾
PBMs, led by CVS Caremark, Express Scripts (Cigna), and OptumRx (UnitedHealth), negotiate drug prices with manufacturers and set reimbursement rates paid to pharmacies for each prescription dispensed. Reimbursement rates often approach or fall below dispensing costs for generics, squeezing margins for independent pharmacies. CVS Health's vertical integration with Caremark creates structural advantages, while independents rely on cooperative purchasing groups to maintain viability.
Why are CVS and Walgreens closing hundreds of stores? ▾
Both chains overbuilt retail footprints during decades of aggressive expansion. E-commerce growth, particularly Amazon Pharmacy and direct mail-order fulfillment, has reduced front-store foot traffic. PBM reimbursement compression and rising labor costs (pharmacist wages, staffing mandates) have eroded per-store profitability. Both companies announced 900+ closures to consolidate into higher-performing locations and redirect investment toward primary care clinics and digital health services.
What role does specialty pharmacy play in this subsector? ▾
Specialty pharmacy dispenses high-cost biologic drugs, oncology treatments, and gene therapies that require cold-chain handling, patient counseling, and outcomes monitoring. This segment generates outsized revenue per prescription and is growing rapidly as the pharmaceutical pipeline shifts toward biologics. CVS Specialty, AllianceRx Walgreens, and independent specialty pharmacies like PharMerica compete for payer contracts and manufacturer distribution agreements.
How is pharmacy scope of practice expanding? ▾
States including California (SB 493), Oregon, and Colorado have granted pharmacists prescriptive authority for hormonal contraceptives, smoking cessation medications, travel vaccines, and naloxone. This scope expansion positions pharmacies as primary care access points, particularly in underserved areas. The clinical revenue from these services partially offsets declining dispensing margins and differentiates brick-and-mortar locations from mail-order competitors.

Questions about how we source industry data? See our data sources FAQ.

Don't see your industry?

We can generate a report for any NAICS-classified industry in the US. Professional PDF delivered in 48 hours.